Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. News & events
Filter by
  • Filter by
  • Remove this filter Infectious disease: Rotavirus infection
  • Remove this filter Public health area: Active immunisation
  • Infectious disease
    • Rotavirus infection (4)
    • Vaccine preventable diseases (4)
  • Public health area
    • Active immunisation (4)
    • Immunisation (4)
    • Vaccination (4)
    • Epidemiology (1)
    • Vaccine safety (1)
  • Country
    • Europe (3)
    • Asia (1)
  • Type
    • News (4)
    • ECDC comment (4)
  • All (4)
  • News (4)
  • Page 1 of 1 // 4 Results found
    • Sort by:

News

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trialArchived

ECDC comment - 14 Sep 2011

These article published in The Lancet provide new data for the efficacy of oral pentavalent rotavirus vaccine for prevention of severe rotavirus – related gastroenteritis in infant in developing countries

  • Asia
  • Immunisation
  • Rotavirus infection

News

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in AustriaArchived

ECDC comment - 23 Mar 2011

This paper describes the epidemiology of rotavirus (RV) in Austrian children before and during universal mass campaign.

  • Austria
  • Epidemiology
  • Immunisation
  • Rotavirus infection

News

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in IrelandArchived

ECDC comment - 10 Oct 2011

Rotavirus gastroenteritis in Ireland is a quite common and unpleasant illness, but severe disease is unusual and death extremely rare. Nonetheless, rotavirus generates considerable direct and indirect costs.

  • Immunisation
  • Ireland
  • Rotavirus infection

News

Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Pre-Term European Infants: A Randomized Phase IIIb StudyArchived

ECDC comment - 1 Feb 2012

Results of this study demonstrated that the RIX4414 vaccine was well tolerated and immunogenic in pre-term European infants: more than 75% of infants had seroconverted 30-83 days after dose 2.

  • Europe
  • Immunisation
  • Rotavirus infection
  • Vaccine safety
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us